by palligoelme@gmail.com | Feb 10, 2026 | Clinical Trials
Conditions: Pits and Fissure Sealants Interventions: Other: Self adhering flowable composite Vertise™ Flow (Kerr, Orange, CA, USA) with fissurotomy.; Other: Self adhering flowable composite Vertise™ Flow (Kerr, Orange, CA, USA) without fissurotomy.; Other:...
by palligoelme@gmail.com | Feb 10, 2026 | Clinical Trials
Conditions: Stress Ulcers; Reflux Episodes Interventions: Drug: Esomeprazole Sponsors: Asian Institute of Gastroenterology, India Not yet recruiting Conditions: Stress Ulcers; Reflux Episodes Interventions: Drug: Esomeprazole Sponsors: Asian Institute of...
by palligoelme@gmail.com | Feb 10, 2026 | Clinical Trials
Conditions: Non-binary Sponsors: University Hospital, Ghent; IPSOS Completed Conditions: Non-binary Sponsors: University Hospital, Ghent; IPSOS Completed
by palligoelme@gmail.com | Feb 10, 2026 | Clinical Trials
Conditions: Sepsis; Septic Shock Interventions: Drug: Extended beta-lactam antibiotics; Drug: Intermittent Beta-lactam antibiotics Sponsors: Assiut University Not yet recruiting Conditions: Sepsis; Septic Shock Interventions: Drug: Extended beta-lactam antibiotics;...
by palligoelme@gmail.com | Feb 9, 2026 | Clinical Trials
Conditions: Treatment of Non-monosymptomatic Nocturnal Enuresis Interventions: Drug: Mirabegron 25 MG Sponsors: Menoufia University Active, not recruiting Conditions: Treatment of Non-monosymptomatic Nocturnal Enuresis Interventions: Drug: Mirabegron 25 MG Sponsors:...
